文献速递肿瘤 PET/CT放射性药物与辐射防护

18F-FDG与18F-FGln PET/CT鉴别良性肾上腺结节与淋巴瘤

Benign Adrenal Nodule Mimicking Lymphoma Differentially Diagnosed by 18F-FDG and 18F-FGln PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

一例58岁女性疑似小肠恶性肿瘤患者行18F-FDG与18F-FGln PET/CT鉴别诊断与分期。18F-FDG显示左肾上腺局灶性摄取增高,而18F-FGln未见异常;术后病理证实肠道为外周T细胞淋巴瘤,肾上腺经CT随访2年余确定为良性。

要点

  • 18F-FDG与18F-FGln PET/CT可用于鉴别肾上腺病灶的良恶性。
  • 18F-FGln在良性肾上腺结节中未见异常摄取,而淋巴瘤呈高摄取。
  • 肾上腺良性病变可经CT随访2年余确认。

核心结论

  • 18F-FGln PET/CT有助于鉴别18F-FDG高摄取但良性肾上腺结节与肠道淋巴瘤。

研究设计与样本

  • 病例报告:一例58岁女性疑似小肠恶性肿瘤患者行18F-FDG与18F-FGln PET/CT检查。

主要发现

  • 18F-FDG与18F-FGln PET均显示部分小肠病灶一致高代谢。
  • 18F-FDG显示左肾上腺局灶性摄取增高,18F-FGln未见异常活动。
  • 术后病理证实肠道外周T细胞淋巴瘤,肾上腺经CT随访2年余确定为良性。

关键数值与推荐

  • 18F-FDG显示左肾上腺局灶性摄取增高而18F-FGln无异常,肾上腺病灶经CT随访2年余确认为良性。

临床怎么用

  • 对18F-FDG高摄取的肾上腺病灶,可考虑18F-FGln PET/CT辅助鉴别良恶性。

局限性

  • 为单例病例报告,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-FDG and 18F-(2S,4R)4-fluoroglutamine (18F-FGln) PET/CT were performed in a 58-year-old woman with suspected small intestinal malignancy for differential diagnosis and staging. 18F-FDG and 18F-FGln PET images showed consistent intense hypermetabolic lesion activity in part of the small intestine. Moreover, 18F-FDG/PET demonstrated a focal of increased radiotracer uptake in left adrenal lesion, which did not show abnormal activity on 18F-FGln/PET. The postoperative pathology confirmed that it was a peripheral T-cell lymphomas of the intestine, and the adrenal lesion was considered benign after continuous CT follow-up for more than 2 years.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Xu X, Zhu H, Kung HF, et al. Benign Adrenal Nodule Mimicking Lymphoma Differentially Diagnosed by 18F-FDG and 18F-FGln PET/CT. Clin Nucl Med. 2021. PMID: 33661191. doi:10.1097/RLU.0000000000003550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。